Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
413
mi
from 43215
Fort Washington, PA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Philadelphia Institute of Dermatology
413
mi
from 43215
Fort Washington, PA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
333
mi
from 43215
Nashville, TN
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Dermatology Research Associates
333
mi
from 43215
Nashville, TN
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
925
mi
from 43215
Arlington, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Arlington Research Center
925
mi
from 43215
Arlington, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
996
mi
from 43215
Houston, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Suzanne Bruce & Associates, PA
996
mi
from 43215
Houston, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
1137
mi
from 43215
San Antonio, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Dermatology Clinical Research Center of San Antonio
1137
mi
from 43215
San Antonio, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
995
mi
from 43215
Houston, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Center for Clinical Studies
995
mi
from 43215
Houston, TX
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
1510
mi
from 43215
Salt Lake City, UT
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Dermatology Research Center
1510
mi
from 43215
Salt Lake City, UT
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
272
mi
from 43215
Lynchburg, VA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
The Education and Research Foundation, Inc.
272
mi
from 43215
Lynchburg, VA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
422
mi
from 43215
Norfolk, VA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Virginia Clinical Research, Inc.
422
mi
from 43215
Norfolk, VA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated:  3/23/2012
1779
mi
from 43215
Spokane, WA
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
Status: Archived
Updated: 3/23/2012
Premier Clinical Research
1779
mi
from 43215
Spokane, WA
Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis
A Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study to Assess the Potential Effect of Topically Applied Imiquimod Cream on Atrial Ectopy in Patients With Actinic Keratosis
Status: Enrolling
Updated:  4/19/2012
930
mi
from 43215
Fort Meyers, FL
Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis
A Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study to Assess the Potential Effect of Topically Applied Imiquimod Cream on Atrial Ectopy in Patients With Actinic Keratosis
Status: Enrolling
Updated: 4/19/2012
Comprehensive Phase One
930
mi
from 43215
Fort Meyers, FL
Click here to add this to my saved trials
Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
A Proof of Concept Cases Series on the Use of the Epidermal Expansion System to Harvest and Place Suction Blister Epidermal Grafts on Hypopigmented Skin and Surgical Wounds
Status: Enrolling
Updated:  5/1/2012
479
mi
from 43215
New York, NY
Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
A Proof of Concept Cases Series on the Use of the Epidermal Expansion System to Harvest and Place Suction Blister Epidermal Grafts on Hypopigmented Skin and Surgical Wounds
Status: Enrolling
Updated: 5/1/2012
Laser and Skin Surgery Center of New York
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
910
mi
from 43215
Dallas, TX
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Status: Enrolling
Updated:  5/16/2012
478
mi
from 43215
New York, NY
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Status: Enrolling
Updated: 5/16/2012
New York Eye and Ear Infirmary
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
2091
mi
from 43215
Santa Clara, CA
Clinical Research Facility
2091
mi
from 43215
Santa Clara, CA
Click here to add this to my saved trials
Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts
Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts
Status: Enrolling
Updated:  6/1/2012
430
mi
from 43215
Decatur, GA
Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts
Comparison of Excision Versus Punch Incision in the Treatment of Epidermal Cysts
Status: Enrolling
Updated: 6/1/2012
Atlanta VA Medical Center
430
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue
A Therapeutic Trial of Intralesional Bevacizumab in Patients With Non-pedunculated Keloids
Status: Enrolling
Updated:  6/6/2012
477
mi
from 43215
New York, NY
Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid Tissue
A Therapeutic Trial of Intralesional Bevacizumab in Patients With Non-pedunculated Keloids
Status: Enrolling
Updated: 6/6/2012
Michael H. Tirgan, MD
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Epidemiology Study of Keloid
Epidemiology Study of Keloid
Status: Enrolling
Updated:  6/6/2012
477
mi
from 43215
New York, NY
Epidemiology Study of Keloid
Epidemiology Study of Keloid
Status: Enrolling
Updated: 6/6/2012
Michael H. Tirgan, MD
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Web Based Investigation of Natural History of Keloid; An Online Survey of Patients With Keloid
Web Based Investigation of Natural History of Keloid; An Online Survey of Patients With Keloid
Status: Enrolling
Updated:  6/6/2012
477
mi
from 43215
New York, NY
Web Based Investigation of Natural History of Keloid; An Online Survey of Patients With Keloid
Web Based Investigation of Natural History of Keloid; An Online Survey of Patients With Keloid
Status: Enrolling
Updated: 6/6/2012
Michael H. Tirgan, MD
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study of Psycho-Social Impact of Keloid
Study of Psycho-Social Impact of Keloid
Status: Enrolling
Updated:  6/6/2012
477
mi
from 43215
New York, NY
Study of Psycho-Social Impact of Keloid
Study of Psycho-Social Impact of Keloid
Status: Enrolling
Updated: 6/6/2012
Michael H. Tirgan MD
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Keloid Tissue Bank
Keloid Tissue Bank - Longitudinal Clinical Data Repository; A Genomic and Molecular Research to Identifying Molecular Markers and Signal Transduction Pathways in Keloid; and Correlations With the Natural History of the Disease.
Status: Enrolling
Updated:  6/9/2012
477
mi
from 43215
New York, NY
Keloid Tissue Bank
Keloid Tissue Bank - Longitudinal Clinical Data Repository; A Genomic and Molecular Research to Identifying Molecular Markers and Signal Transduction Pathways in Keloid; and Correlations With the Natural History of the Disease.
Status: Enrolling
Updated: 6/9/2012
Michael H. Tirgan, MD
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
698
mi
from 43215
Fort Smith, AR
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
698
mi
from 43215
Fort Smith, AR
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
2091
mi
from 43215
Santa Clara, CA
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
2091
mi
from 43215
Santa Clara, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
1154
mi
from 43215
Aurora, CO
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
522
mi
from 43215
Bridgeport, CT
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
522
mi
from 43215
Bridgeport, CT
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
164
mi
from 43215
Ann Arbor, MI
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
559
mi
from 43215
Rochester, MN
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
1751
mi
from 43215
Henderson, NV
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
1751
mi
from 43215
Henderson, NV
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
468
mi
from 43215
Newark, NJ
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
1333
mi
from 43215
Albuquerque, NM
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
302
mi
from 43215
Ashville, NC
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
302
mi
from 43215
Ashville, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
127
mi
from 43215
Cleveland, OH
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
2026
mi
from 43215
Portland, OR
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
910
mi
from 43215
Dallas, TX
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated:  6/28/2012
1513
mi
from 43215
Salt Lake City, UT
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Gevokizumab in Subjects With Moderate to Severe Acne Vulgaris
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Photoprovocation Testing in Subjects With Cutaneous Lupus
Photoprovocation Testing in Subjects With Cutaneous Lupus
Status: Enrolling
Updated:  7/20/2012
414
mi
from 43215
Philadelphia, PA
Photoprovocation Testing in Subjects With Cutaneous Lupus
Photoprovocation Testing in Subjects With Cutaneous Lupus
Status: Enrolling
Updated: 7/20/2012
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Fresolimumab In Systemic Sclerosis
OPEN LABEL TRIAL OF ANTI-TGF-BETA MAB, FRESOLIMUMAB, IN SYSTEMIC SCLEROSIS - A PHASE ONE BIOMARKER TRIAL
Status: Enrolling
Updated:  7/25/2012
643
mi
from 43215
Boston, MA
Fresolimumab In Systemic Sclerosis
OPEN LABEL TRIAL OF ANTI-TGF-BETA MAB, FRESOLIMUMAB, IN SYSTEMIC SCLEROSIS - A PHASE ONE BIOMARKER TRIAL
Status: Enrolling
Updated: 7/25/2012
Boston University School of Medicine; Rheumatology/Arthritis Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.
Status: Enrolling
Updated:  8/21/2012
422
mi
from 43215
Norfolk, VA
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
A Model for the Implementation of the Cervical Cancer Screening and HPV Vaccination in the Emergency Department: a Pilot Study.
Status: Enrolling
Updated: 8/21/2012
Sentara Norfolk General Hospital
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Treatment of Vitiligo With Low-energy Visible Light Laser
Treatment of Recalcitrant Forms of Vitiligo With a Low-energy 635 nm Visible Light Laser
Status: Enrolling
Updated:  9/4/2012
166
mi
from 43215
Detroit, MI
Treatment of Vitiligo With Low-energy Visible Light Laser
Treatment of Recalcitrant Forms of Vitiligo With a Low-energy 635 nm Visible Light Laser
Status: Enrolling
Updated: 9/4/2012
Henry Ford Hospital Department of Dermatology. 3031 W. Grand Blvd. Suite 800
166
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated:  9/12/2012
188
mi
from 43215
Louisville, KY
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated: 9/12/2012
Dermatology Specialists Research
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated:  9/12/2012
167
mi
from 43215
Richmond, KY
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated: 9/12/2012
Melissa L.F. Knuckles MD, PSC
167
mi
from 43215
Richmond, KY
Click here to add this to my saved trials
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated:  9/12/2012
1059
mi
from 43215
Austin, TX
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated: 9/12/2012
DermResearch, Inc.
1059
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated:  9/12/2012
272
mi
from 43215
Lynchburg, VA
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
A Multicenter, Randomized, Controlled, Double-masked, Crossover Design Study to Compare Efficacy and Assess Safety of CD07805/47 Gel 0.5% Applied Once Daily vs Azelaic Acid Gel 15% Applied Twice Daily in Subjects With Erythema of Rosacea
Status: Enrolling
Updated: 9/12/2012
The Education and Research Foundation, Inc.
272
mi
from 43215
Lynchburg, VA
Click here to add this to my saved trials
24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
A Randomized, Double -Blind,, Sham-Device-Controlled, Multicenter, 24-Week Clinical Trial to Evaluate the Safety and Effectiveness of the iRestore ™ Hair Rejuvenation System in the Treatment of Male and Female Androgeneticalopecia
Status: Enrolling
Updated:  9/12/2012
475
mi
from 43215
Paramus, NJ
24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
A Randomized, Double -Blind,, Sham-Device-Controlled, Multicenter, 24-Week Clinical Trial to Evaluate the Safety and Effectiveness of the iRestore ™ Hair Rejuvenation System in the Treatment of Male and Female Androgeneticalopecia
Status: Enrolling
Updated: 9/12/2012
TKL Research
475
mi
from 43215
Paramus, NJ
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
2055
mi
from 43215
Eugene, OR
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Allergy and Asthma Research Group
2055
mi
from 43215
Eugene, OR
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
2029
mi
from 43215
Lake Oswego, OR
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Baker Allergy, Asthma and Dermatology Research Center
2029
mi
from 43215
Lake Oswego, OR
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
2021
mi
from 43215
Portland, OR
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Allergy Associates Research Center
2021
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
2000
mi
from 43215
Renton, WA
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Rainer Center for Clinical Research, Inc
2000
mi
from 43215
Renton, WA
Click here to add this to my saved trials
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated:  9/17/2012
2006
mi
from 43215
Seattle, WA
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Status: Enrolling
Updated: 9/17/2012
Asthma Inc
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT)
A Pilot Clinical Trial To Reduce Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne
Status: Enrolling
Updated:  9/18/2012
643
mi
from 43215
Boston, MA
Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT)
A Pilot Clinical Trial To Reduce Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne
Status: Enrolling
Updated: 9/18/2012
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials